ATE388173T1 - Polymere modifizierungsmittel und pharmazeutische zusammensetzungen - Google Patents

Polymere modifizierungsmittel und pharmazeutische zusammensetzungen

Info

Publication number
ATE388173T1
ATE388173T1 AT04723056T AT04723056T ATE388173T1 AT E388173 T1 ATE388173 T1 AT E388173T1 AT 04723056 T AT04723056 T AT 04723056T AT 04723056 T AT04723056 T AT 04723056T AT E388173 T1 ATE388173 T1 AT E388173T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
polymeric modifiers
modifiers
polymeric
pharmaceutical
Prior art date
Application number
AT04723056T
Other languages
English (en)
Inventor
Yuji Kasuya
Masashi Honma
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Application granted granted Critical
Publication of ATE388173T1 publication Critical patent/ATE388173T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F216/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical
    • C08F216/12—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical by an ether radical
    • C08F216/14—Monomers containing only one unsaturated aliphatic radical
    • C08F216/16—Monomers containing no hetero atoms other than the ether oxygen
    • C08F216/18—Acyclic compounds
    • C08F216/20—Monomers containing three or more carbon atoms in the unsaturated aliphatic radical
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/04—Anhydrides, e.g. cyclic anhydrides
    • C08F222/06—Maleic anhydride
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • C08F8/32—Introducing nitrogen atoms or nitrogen-containing groups by reaction with amines
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F216/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical
    • C08F216/12—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical by an ether radical
    • C08F216/14—Monomers containing only one unsaturated aliphatic radical
    • C08F216/1416—Monomers containing oxygen in addition to the ether oxygen, e.g. allyl glycidyl ether
    • C08F216/1425—Monomers containing side chains of polyether groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT04723056T 2003-03-24 2004-03-24 Polymere modifizierungsmittel und pharmazeutische zusammensetzungen ATE388173T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003080389 2003-03-24
JP2003355853 2003-10-16
JP2003426598 2003-12-24

Publications (1)

Publication Number Publication Date
ATE388173T1 true ATE388173T1 (de) 2008-03-15

Family

ID=33101948

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04723056T ATE388173T1 (de) 2003-03-24 2004-03-24 Polymere modifizierungsmittel und pharmazeutische zusammensetzungen

Country Status (23)

Country Link
US (1) US7811556B2 (de)
EP (1) EP1611173B1 (de)
KR (1) KR20050118201A (de)
AR (1) AR043917A1 (de)
AT (1) ATE388173T1 (de)
AU (1) AU2004223964B2 (de)
BR (1) BRPI0408526A (de)
CA (1) CA2520450C (de)
CL (1) CL2004000633A1 (de)
DE (1) DE602004012241T2 (de)
DK (1) DK1611173T3 (de)
ES (1) ES2301978T3 (de)
HK (1) HK1078598A1 (de)
IL (1) IL170489A (de)
MX (1) MXPA05010289A (de)
NZ (1) NZ542352A (de)
PA (1) PA8598701A1 (de)
PE (1) PE20041067A1 (de)
PL (1) PL1611173T3 (de)
PT (1) PT1611173E (de)
SI (1) SI1611173T1 (de)
TW (1) TWI293882B (de)
WO (1) WO2004085500A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2090599A1 (de) * 2008-02-13 2009-08-19 Construction Research and Technology GmbH Copolymer mit Polyetherseitenketten und Dicarbonsäurederivatbausteinen

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1217005A (en) * 1916-05-08 1917-02-20 Judson D Mccarthy Photographic-printing frame.
DE3260845D1 (en) * 1981-01-16 1984-11-08 Nippon Catalytic Chem Ind Copolymer and method for manufacture thereof
JP2621308B2 (ja) 1987-03-13 1997-06-18 日本油脂株式会社 アリルエーテル−無水マレイン酸共重合体
JP2701295B2 (ja) 1987-03-13 1998-01-21 日本油脂株式会社 アリルエーテル−無水マレイン酸共重合体
JP2803265B2 (ja) 1989-12-26 1998-09-24 日本油脂株式会社 変性ポリペプチドおよびその用途
US5158622A (en) * 1991-02-12 1992-10-27 Betz Laboratories, Inc. Method and composition for treatment of aluminum
JP3271265B2 (ja) * 1991-03-07 2002-04-02 日本油脂株式会社 修飾プロテアーゼ
JP3035675B2 (ja) * 1991-08-21 2000-04-24 株式会社コーセー 修飾スーパーオキシドディスムターゼ
CA2080174A1 (en) * 1991-10-11 1993-04-12 John E. Hayes Polymer polyol dispersants from polymers containing anhydride groups
JP3106265B2 (ja) 1992-05-26 2000-11-06 株式会社コーセー 修飾リゾチーム
US6004583A (en) * 1995-03-22 1999-12-21 Orex Pharmaceutical Development Corp. Protein-containing polymer composition for oral administration
US6369027B1 (en) 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin
IT1293087B1 (it) 1997-07-10 1999-02-11 Isi Ist Sierovaccinogeno Ital Microparticelle a base di materiali polimerici ibridi per il rilascio controllato di molecole biologicamente attive, procedimento per la
DE19834173A1 (de) * 1997-08-01 1999-02-04 Sueddeutsche Kalkstickstoff Copolymere auf Basis von ungesättigten Dicarbonsäure-Derivaten und Oxyalkylenglykol-Alkenylethern
JPH11302199A (ja) 1998-04-16 1999-11-02 Sankyo Co Ltd 薬物運搬体を構成するグラフト共重合体
DE19847868C2 (de) * 1998-10-16 2003-09-25 Clariant Gmbh Sprengstoffe, enthaltend modifizierte Copolymere aus Polyisobutylen und Maleinsäureanhydrid als Emulgatoren
CA2358463A1 (en) * 1999-01-08 2000-07-13 Virginia Commonwealth University Polymeric delivery agents and delivery agent compounds
ITTO20000942A1 (it) 2000-10-10 2001-01-10 Sergio Guzzoni Pricedimento per la gestione di interscambi di messaggi tra fornitorie clienti di servizi di telefonia.
JP2003105040A (ja) 2001-09-28 2003-04-09 Nof Corp 共重合体の製造方法およびその用途
JP5109218B2 (ja) 2001-09-28 2012-12-26 日油株式会社 共重合体の製造方法

Also Published As

Publication number Publication date
MXPA05010289A (es) 2005-11-17
KR20050118201A (ko) 2005-12-15
AU2004223964B2 (en) 2007-02-22
PE20041067A1 (es) 2005-01-22
PL1611173T3 (pl) 2008-08-29
TWI293882B (en) 2008-03-01
SI1611173T1 (sl) 2008-08-31
BRPI0408526A (pt) 2006-03-07
CL2004000633A1 (es) 2005-01-21
EP1611173A1 (de) 2006-01-04
DK1611173T3 (da) 2008-06-23
US20060062754A1 (en) 2006-03-23
NZ542352A (en) 2007-02-23
ES2301978T3 (es) 2008-07-01
DE602004012241D1 (de) 2008-04-17
AU2004223964A1 (en) 2004-10-07
DE602004012241T2 (de) 2009-03-12
PA8598701A1 (es) 2005-02-04
WO2004085500A1 (en) 2004-10-07
US7811556B2 (en) 2010-10-12
HK1078598A1 (en) 2006-03-17
AR043917A1 (es) 2005-08-17
CA2520450A1 (en) 2004-10-07
CA2520450C (en) 2009-11-03
PT1611173E (pt) 2008-05-23
IL170489A (en) 2009-06-15
TW200501986A (en) 2005-01-16
EP1611173B1 (de) 2008-03-05

Similar Documents

Publication Publication Date Title
IL170758A0 (en) 7-amino-isoindolyl compounds and their pharmaceutical uses
HK1084883A1 (en) 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
TWI349664B (en) Benzimidazole derivatives: preparation and pharmaceutical applications
DE602004021904D1 (de) Gyraseinhibitoren und deren verwendungen
DK1620118T3 (da) Reversible pegylerede lægemidler
DE602005015349D1 (de) Verbesserte kautschukmodifizierte monovinyliden-aromapolymere und daraus hergestellte erzeugnisse
IL176248A0 (en) N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
DE60322020D1 (de) Alkali-quellbare assoziative polymere, methode und zusamensetzungen
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
IL170313A (en) Diarylcycloalkyl derivatives and pharmaceutical compositions comprising them
DK1587478T3 (da) Farmaceutisk sammensætning
IS7491A (is) Benzoxazínon-afleidd efnasambönd, framleiðsla þeirra og notkun sem lyf
ATE381931T1 (de) Nicht-peptidische bradykinin-antagonisten und pharmazeutische zusammensetzungen daraus
PL394604A1 (pl) Pochodna winyloazacykloalkanowa, jej zastosowanie oraz kompozycja farmaceutyczna
DE60336025D1 (de) Kollimator und bestrahler
DE602005012287D1 (de) Biotinylierte hexadecasaccharide, pharmazeutische zusammensetzungen daraus und deren verwendung
ATE448780T1 (de) Pharmazeutische modafinil-zusammensetzungen mit modifizierter freisetzung
SI1673349T1 (sl) Derivati benzimidazola: priprava in farmacevtske uporabe
DE60310526D1 (de) Ivabradin enthaltende pharmazeutische zusammensetzung mit oraler dispersion
DE60329614D1 (de) Polymerzusammensetzung sowie diese enthaltende darreichungsformen
DE602004022169D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
IS8227A (is) Lyf
ATE388173T1 (de) Polymere modifizierungsmittel und pharmazeutische zusammensetzungen
DK1750765T3 (da) Farmaceutisk antimykobakteriesammensætning omfattende et antituberkulöst lægemiddel
GB0309509D0 (en) Pharmaceutical compositions and their uses

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1611173

Country of ref document: EP

REN Ceased due to non-payment of the annual fee